Avid Bioservices, Inc. Common Stock
CDMO
CDMO was delisted on the 4th of February, 2025.
0 hedge funds and large institutions have $0 invested in Avid Bioservices, Inc. Common Stock in 2025 Q2 according to their latest regulatory filings, with 0 funds opening new positions, increasing their positions, reducing their positions, and 2 closing their positions.
100% less funds holding
Funds holding: 2 → 0 (-2)
100% less capital invested
Capital invested by funds: $2.31K → $0 (-$2.31K)
100% less first-time investments, than exits
New positions opened: 0 | Existing positions closed: 2
Top Buyers
Top Sellers
| 1 |
TCWM
Total Clarity Wealth Management
St. Charles,
Illinois
|
-$2.29K |
| 2 |
IA
IFP Advisors
Tampa,
Florida
|
-$25 |
CDMO Hedge Fund Activity: Q2 2025 in Review
0 of the 7,595 institutional investors tracked by Wall St. Rank reported a position in Avid Bioservices, Inc. Common Stock (CDMO) for Q2 2025, worth a combined $0 — down 100% from $2.31K a quarter earlier.
Sellers outnumbered buyers: 2 funds closed out of CDMO and 0 opened new positions — a net loss of 2 holders — while 0 trimmed existing stakes and 0 added.
The largest seller was Total Clarity Wealth Management, exiting entirely with an estimated $2.29K sold.
- 0 institutional investors held Avid Bioservices, Inc. Common Stock (CDMO) as of Q2 2025, down from 2 in Q1 2025.
- Funds reported $0 of Avid Bioservices, Inc. Common Stock stock for Q2 2025, down 100% quarter-over-quarter.
- 0 funds opened new Avid Bioservices, Inc. Common Stock positions in Q2 2025 and 2 closed out, a net change of -2 holders.
- The largest Avid Bioservices, Inc. Common Stock seller in Q2 2025 was Total Clarity Wealth Management, an estimated $2.29K sold.
Based on aggregated 13F filings for Q2 2025.